NCT00071006 2012-06-08AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)PfizerPhase 2 Completed12 enrolled 5 charts